NEW MJ NEWS

AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2021 financial results on Wednesday, February 2, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-and-full-year-2021-earnings-conference-call-301451929.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Organigram Holdings Inc. (OGRMF) recognized by Best in Biz Awards 2018

Organigram recognized by Best in Biz Awards 2018 Organigram Holdings Inc. (TSX…

$BLPG Services Provides Complete Bookkeeping Solution to Cannabis Industry

Blue Line Advisory Services Provides Complete Bookkeeping Solution to Cannabis Industry DENVER,…

$THCZ Announces Third Production Run This Quarter

Totally Hemp Crazy, Inc. Announces Third Production Run This Quarter of Rocky…

Tetra Bio-Pharma Inc. (TBPMF) Receives Health Canada Approval for Phase 2 Cannabis Oil Trial

Tetra Bio-Pharma Receives Health Canada Approval for Phase 2 Cannabis Oil Trial…